chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vertigo, Vomiting
Clinical narrative: Severe stomach ache; muscle and joint aches and pains; Chilblains; muscle and joint aches and pains; nausea; fever; injection site pain; Vertigo; vomiting; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6200) via an unspecified route of administration, administered in left arm on 03Mar2021 at 03:00 PM (at the age of 65 years old) as single dose, for COVID-19 immunisation. The patient's medical history included hypothyroidism, MZ on Serpina1 (as reported) and known allergies to shrimp. The patient had no COVID prior vaccination and she was not tested for COVID post-vaccination. The patient also did not receive other vaccine in four weeks. Concomitant medications included levothyroxine, thyroid (ARMOUR THYROID) and ibuprofen (ADVIL); all were taken for an unspecified indications, start and stop dates were not reported. On 03Mar2021 at 11:00 PM, it was reported that the patient experienced severe stomachache with nausea and vomiting about 12 hours post injection (as reported). She also experienced chilblains, fever, muscle and joint aches, injection site pain 8 hours post injection and vertigo. The patient did not received treatment for the adverse events. The outcome of the events was not recovered.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity
Clinical narrative: Severe headache; pain in thighs; dizziness; extreme fatigue; This is a spontaneous report from a contactable consumer (patient, self-reported). A 68-year-female patient (age at vaccination was 68 Years) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: unknown and expiry date was not provided), via an unspecified route of administration, on 03Feb2021, as a single dose for COVID-19 immunization. The patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not provided), via an unspecified route of administration, on 24Feb2021, as a single dose for COVID-19 immunization. The facility was unknown where the most recent COVID-19 vaccine was administered. The patient was not pregnant at the time of vaccination. The patient's medical history included diabetes mellitus. It was unknown if the patient had allergies to medications, food, or other products. Concomitant medications were not reported. It was unknown if patient had vaccine in four weeks and unknown if other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that on 06Feb2021, the patient had severe headache, pain in thighs, dizziness, and extreme fatigue. The patient received tyelonol as treatment for the adverse events. On 27Feb2021, the patient experienced unknown symptoms which was resolved on 28Feb2021. Outcome of the event severe headache was unknown and for all other events, it was recovered on an unknown date.  Follow-up attempts are completed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: broke out in a terribly painful shingles rash on her upper left chest; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in left arm on 02Mar2021 10:00 (Batch/Lot number was not reported) (at age 65 years old) as single dose for covid-19 immunisation. The patient is not pregnant at the time of vaccination. Medical history included no thyroid, heart condition, total knee replacement, DJD, shingles, and known allergies (unspecified) all from an unknown date. No covid prior to vaccination and was not covid tested post vaccination. Concomitant medications included levothyroxine and liothyronine, both taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 on 09Feb2021 08:00 (lot no: EL9269) in left arm for COVID-19 immunization. No other vaccine in four weeks. On day 2 following her second vaccine, on 04Mar2021, the patient broke out in a terribly painful shingles rash on her upper left chest. She has had shingles before and been vaccinated fully for shingles. It is now day 3 and rash is still painfully present. Treatment not given for the event. The patient had not recovered from the event.   Information about lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Oligomenorrhoea, Vaccination site pain, Vaccination site swelling
Clinical narrative: 11 months without menstruation, in menopause phase; four days just after the shot, I got it back; Very strong pain in left arm started 3 or 4 hours after the shot and lasted 48 hours; Area of shot swelled; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in left arm on 01Mar2021 09:30 as single dose for covid-19 immunization. Medical history included retinal operation, surgery, cataract operation, appendicitis, reflux gastritis (retina detachments and surgeries on both eyes as well as cataracts). No chronic condition reported for Appendicitis. Concomitant medication(s) included pantoprazole sodium 40mg on unspecified date. On 01Mar2021 at 13:00, patient experienced very strong pain in left arm started, area of shot swelled and the patient was 11 months without menstruation, in menopause phase; four days just after the shot, I got it back. The patient did not receive any other vaccine in four weeks. The patient did not have COVID prior vaccination and post vaccination, patient had not tested with covid 19. No known allergies reported for patient. No treatment received for these events. The outcome of event was recovered on an unknown date. Upon follow-up on 29Mar2021, query response received regarding confirmation on patient and awareness date of events as: Yes, I am the patient in the report. I got the vaccine in the left arm.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 43-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 04Mar2021 09:30 (Batch/Lot number was not reported) (at the age of 43 years old) at 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Following the COVID vaccine shot #1, the patient developed shingles on the left side of the abdomen which was first discovered on Thursday 04Mar2021, around 21:00. After discovering the first cluster of blisters, two additional clusters appeared, one on lower left abdomen and one on low back to the left of the spine. The outcome of the event was unknown.  Information on the lot/ batch number has been requested.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore upper arm; This is a spontaneous report received from a contactable consumer (Patient). A 41-year-old male patient received first dose of BNT162B2 (Pfizer COVID-19 Vaccine, Solution for injection, lot numbe: unknown), via an unspecified route of administration, administered in left arm on 08Mar2021 at 01:15 PM (at the age of 41-years-old) as 1st, single dose for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. Patient had no known allergies. The patient did not receive any other vaccine in four weeks of vaccination. The patient did not receive any other medications in two weeks. The patient was not diagnosed with COVID prior vaccination. On 8Mar2021 (same day of vaccination), patient had sore upper arm. The patient did not receive any treatment for event. The patient was given vaccine at workplace clinic. The patient had not been tested for COVID post vaccination. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with Shingles; This is a spontaneous report from a contactable consumer. An 83-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 24Jan2021 10:45 (Lot was not reported) as 1 st dose, single then on 17Feb2021 10:45 (Lot was not reported) as 2 nd dose, single; both via an unspecified route of administration in left arm (at the age of 83-years-old) for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccination facility type was a hospital. It was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, was unknown if patient been tested for COVID-19. The patient's medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient was diagnosed with Shingles on 05Mar2021. An unspecified treatment was received for the adverse event. The consumer considered the event as non-serious as did not results in death, non-life threatening, did not cause/prolong hospitalization, not disabling/incapacitating and no congenital anomaly/birth defect. The outcome of the event was recovering.  Information on the lot/batch number has been requested.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Inflammation, Pain
Clinical narrative: feeling pain; inflammation Sunday night, beside my armpit, almost in my back; shingles; This is a spontaneous report from a contactable consumer (patient) reported for self. A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, at the age of 65 years (for confirmation), on 02Mar2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated, "I received the first dose of the Covid 19 vaccine on 02Mar2021. I started feeling pain and inflammation Sunday night (07Mar2021), beside my armpit, almost in my back. On Monday (Mar2021) the pain got worst. I went to my doctor and she told me to it was shingles and that it was one of the effects of the vaccine." The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient). A patient (Age: 61; Unit: Unknown) of unspecified gender received the first dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After receiving the first Covid shot, the next day the patient had a small bump and then more; turns out it is shingles. The patient has no more stress than normal, the patient is in physical shape as he/she workout 5 days a week and the patient's immune system is fine. There is no question in the patient's mind that it was triggered by the vaccine shot. However, the patient would still have gotten the shot. The patient is scheduled to get the 2nd shot on the 30th. The outcome of the event was unknown.    Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Feeling abnormal
Clinical narrative: "I don't know what's wrong with e today, I had that Covid vaccine that's what's wrong; This is a spontaneous report from a Pfizer-sponsored program, from a contactable consumer (patient).   A 76-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation and estrogens conjugated (PREMARIN) vaginal cream, route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history and the patient's concomitant medications were not reported.  The patient experienced "I don't know what's wrong with a today, I had that covid vaccine that's what's wrong (feeling abnormal)" (non-serious) on an unspecified date with outcome of unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This is a spontaneous report from a contactable pharmacist.  A 32-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported.  The reporter stated that the patient had first dose of PFIZER-BIONTECH COVID-19 VACCINE and then the patient got a case of the shingles on an unknown date. The reporter wanted to know if this will affect the patient's second dose. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Herpes zoster
Clinical narrative: shingles; pain in her lower back; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Mar2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Three days after, on 10Mar2021, the patient experienced pain in her lower back. On 21Mar2021, she had shingles breakout. They suspected that the vaccine shot was bringing out shingles. They would like to confirm if it would be fine to not let the patient take the 2nd dose. Outcome of the events was unknown.    Information on the lot/ batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient was diagnosed with shingles after the administration of the first dose of the Pfizer's COVID-19 vaccine. The patient received treatment of aciclovir and his physician recommended to postpone the administration for a few days. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Fatigue, Pyrexia
Clinical narrative: Chest Pain; Back Pain; fever; fatigue; This is a spontaneous report from a contactable consumer (patient).  A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6198), dose 2 intramuscular, administered in Arm Right on 07Mar2021 12:00 (the day of vaccination) (at the age of 74 years) as single dose for covid-19 immunisation. Medical history included sleep apnoea (ongoing) from Apr2014 and C-PAP Machine, breast cancer (Mastectomy Radiation) (ongoing) from 05Dec2020 and ongoing Mastectomy Radiation, Shingles, thyroid, blood pressure, Gastroesophageal reflux disease (GERD), Bladder disorder. Historical Vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EM9808) and experienced Chills, Headache, Cough, Sneezing, Difficulty lifting right arm. Concomitant medication(s) included gabapentin (NEURONTIN) taken for herpes zoster; levothyroxine (SYNTHROID) taken for thyroid disorder; lisinopril (ZESTORETIC) taken for blood pressure abnormal; lovastatin (MEVACOR) taken for blood cholesterol; omeprazole (PRILOSEC) taken for gastroesophageal reflux disease (GERD), oxybutynin (DITROPAN) taken for bladder disorder. On 09Mar2021 01:00, the patient experienced chest pain, back pain, On 08Mar2021, fever, fatigue. Therapeutic measures were taken as a result of chest pain, back pain, fever, fatigue as paracetamol (TYLENOL). The patient had no relevant lab test 2week before COVID vaccine. The outcome of event were recovered on 2021.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with shingles; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Last Wednesday (17Mar2021), patient was diagnosed with shingles and is still suffering from the side effects. She asked her doctor if it is okay to take the second vaccine and they said it was okay, but she is calling to see if it is okay. The outcome of the event was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: developed shingles; This is a spontaneous report from a non-contactable consumer (patient's spouse). An 86-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 21Feb2021 as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient developed shingles and was advised by his physician to wait and get his 2nd dose. The patient received his 2nd dose on 25Mar2021 after the shingles went away and was asking if this timing is ok for the 2nd vaccine dose. The outcome of the event was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles rash; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6205), via an unspecified route of administration, administered in arm left on 09Mar2021 (at the age of 49-years-old) as 1st dose, single for COVID-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. After the patient got the vaccine, he developed a "shingles rash". He would like to know if there are any reports regarding the vaccine causing this side effect. He is due to get his second dose of the vaccine tomorrow (unspecified date) and has considered about that dose causing the same reaction. It was further reported that he is supposed to go get the second dose tomorrow and he is not sure if he should go. Stated after getting the first vaccine he experienced a shingles outbreak 4 days after getting that first dose (13Mar2021), and the shingles was in the same area, on the same shoulder, that he got vaccine, so he thought it might be related. He stated he took a medication; it was a herpes drug, but he forgot the name. It is a drug to stop the duplication of the herpes virus. Therapeutic measures were taken as a result of the event. The outcome of the event was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Incorrect route of product administration
Clinical narrative: diagnosed with Shingles 3/17/21; Route of administration: Subcutaneous; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 subcutaneous on 03Mar2021 (Lot number and expiration date not reported) as 2nd dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was previously vaccinated with the first dose on an unspecified date for Covid-19 immunization. The patient was diagnosed with shingles on 17Mar2021. The outcome of the events was unknown.  Information on the lot/batch number was requested.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: broke out in a shingles rash; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date (after the first dose), the patient broke out in a shingles rash. The patient was concerned if she should receive the second dose. The physician (caller) was asking if there have been any reports of shingles after vaccination that have been documented. The outcome of the event was unknown. Event was reported as non-serious.  Information about batch/lot number has been requested.
Sex: U
Vaccine: COVID19, UNK, UNK
Symptoms: Fatigue, Limb discomfort
Clinical narrative: I got my first shot this week and I felt tired; felt like someone might have grabbed her arm; This is a spontaneous report from a Pfizer-sponsored program, Pfizer RXPathways. A contactable 44-year-old consumer of unspecified gender reported to have received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date in Mar2021, for COVID-19 immunization. Co-suspect drugs also included estrogens conjugated (PREMARIN; vaginal cream) and estrogens conjugated (PREMARIN; tablet), both taken from an unknown date, at unknown dosage, for an unknown indication. Medical history and concomitant medications were not reported. The patient received the first vaccination and felt tired for an hour on an unspecified date in Mar2021. The patient also felt like "someone might have grabbed her arm, kind of arm, not hard but like when you go see a friend you go oh I'm so happy to see you and that was it and it probably lasted for an hour". The patient also stated that never had anything happened to her/him from it and thought the first hour after she/he got it she/he was tired. The action taken in response to the events with estrogens conjugated was unknown. The final events outcome was unknown. Information on the lot/batch number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with Shingles/quite a few sores of the shingles; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at vaccination age of 66-year-old via an unspecified route of administration on 13Mar2021 (Batch/Lot number was not reported) as first dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient reported that she received her first dose of the Pfizer-Biontech Covid19 vaccine on 13Mar2021 and she has since developed and broke out with shingles 4 days ago"(26Mar2021) and she reported "quite a few sores" (quite a few sores of the shingles). She was diagnosed with shingles between Covid19 vaccine doses and may delay her second dose if possible. She is scheduled to get her second dose this Saturday (03Apr2021). She inquired if she should receive her second dose as schedule or defer until her shingles outbreak has resolved. She added that she saw her doctor for treatment of the shingles, and he prescribed her a medication. She mentioned that he didn't have any idea what to do about receiving the second Covid19 vaccine. The outcome of the events was unknown.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient) Pfizer-sponsored program. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Mar2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The received her first dose on 01Mar2021 and she is scheduled to get the second dose on 29Mar2021. The patient is concerned because she had shingles in Mar2021 after the first dose and has been taking steroids. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Eye irritation, Ophthalmic herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient) Pfizer-sponsored program. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Mar2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The received her first dose on 01Mar2021 and she is scheduled to get the second dose on 29Mar2021. The patient is concerned because she had shingles in Mar2021 after the first dose and has been taking steroids. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a rash within 3 days of receiving the first shot of Pfizer Biontech COVID vaccine. Reporter said the physician thought it might be a resurface of shingles. Rash cleared subsequently without any further complications. The outcome of the event rash was recovered while unknown for the event shingles.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles break out right abdomen; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant (including at the time of vaccination) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm left on 26Mar2021 13:45  (Batch/Lot Number: EP6955) at the age of 52-year-old as 2nd dose, single for COVID-19 immunization at the School or Student Health Clinic.  Medical history included Crohn's disease and breast cancer female in 2016. The patient had known allergies with sulfa. Concomitant medications included bupropion (BUPROPION) and tamoxifen (TAMOXIFEN) both taken for unspecified indications and therapy dates. The patient had the first dose of PFIZER-BIONTECH COVID-19 VACCINE on arm left on 05Mar2021 01:45 PM (Batch/Lot Number: EN6203) at the age 52-year-old for COVID-19 immunization. Then, the 2nd dose on 26Mar2021 13:45. At 17:30 (also reported as 4 hours after injection), the patient had shingles break out at the right abdomen which require doctor or other healthcare professional office/clinic visit. The patient was treated with valacyclovir. The patient was not diagnosed with COVID-19 prior to vaccination and not been tested for COVID-19 since vaccination. Outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a Pfizer-sponsored program . A contactable consumer (patient's wife) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 21Feb2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the 1st dose last 21Feb2021 but missed the scheduled 2nd dose because he had shingles. Her husband just received the 2nd dose yesterday, 25Mar2021 and she would like to know if that is okay. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 15Mar2021 as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had his/her Pfizer Vaccine on 15Mar2021, and he/she was currently have shingles on Mar2021, and he/she was due to get the second one in a week. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: A week after the 2nd vaccine, I contracted shingles.; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in left arm on 26Feb2021 (Batch/Lot Number: EN9581) as 1st dose, single for Covid-19 immunisation. Medical history included mitral valve repair replacement. Concomitant medications included flecainide and rivaroxaban (XARELTO). On 25Mar2021, the patient contracted shingles. The patient was treated with valacyclovir. The outcome of the event was recovering.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: breakout of shingles; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation, age at vaccination unknown. Medical history included chickenpox from an unknown date. The patient's concomitant medications were not reported.  The patient experienced breakout of shingles on an unspecified date after having the Pfizer COVID-19 vaccine. She said her doctor has advised her to report her reaction to the vaccine to Pfizer. It might be a long-term effect of the vaccine. The patient commented that it is very unusual that the vaccine does not trigger the chickenpox virus. That could be a high possibility said the doctor. Patient did nothing unusual, no other medical intervention (treatment) aside from the vaccine. Patient had chickenpox as a kid and patient stated it is said the virus stays dormant. Patient have no other health concerns. This vaccination has only been the only thing different. Patient had a breakout 2 months later. Outcome of the event was unknown. The event was reported as non-serious.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on 26Mar2021, as first dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The pharmacist was asking if the company had any information regarding the Pfizer COVID-19 vaccine with acyclovir. A provider contacted the pharmacist and said that a patient received the first dose on 26Mar2021 and now had shingles (from an unspecified date in 2021). They didn't want to interfere with the vaccine by treating the shingles. The event was considered non-serious. The outcome of the event was unknown.  Follow-up attempts are completed; information about batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Disease recurrence, Ear pain, HIV test, Herpes zoster, Toothache
Clinical narrative: diagnosed with shingles; diagnosed with shingles / actually had shingles on my back in my early 30s; mild teeth pain on right side; mild ear pain on right side; This is a spontaneous report from a non-contactable consumer or other non hcp (patient himself). A male patient of an unspecified age (reported as age 63) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 19Mar2021 as first dose, single for COVID-19 immunisation. Medical history included ongoing HIV test positive (reported as for 30 plus years), varicella (reported as I did have chicken pox as a kid), and ongoing herpes zoster (reported as I actually had shingles on my back in my early 30s).  The patient's concomitant medications were not reported. On 21Mar2021, patient felt some swelling in right cheek and neck and stuffiness in his ear. Over the next two days, patient had some mild tingling on right side of face and red marks that appeared. On 25Mar2021, patient went to urgent care and was diagnosed with shingles. Patient then reported that the tingling had disappeared, and just had some mild teeth pain on right side and mild ear pain on right side. Patient felt much improved and noted that the red marks were scabbing. Patient felt fine and noted just little bit of scabs and little irritation in ear and teeth. Patient went back to his doctor on 29Mar2021 and doctor said he was getting the right treatment. Doctor told him the reactions didn't seem like it was related to the vaccine but the timing was close. Patient reported his next schedule of vaccine was on 09Apr2021 and called to check if there was any concern. He reported that he would like to get the vaccine. The patient underwent lab tests and procedures which included HIV test: positive on an unspecified date. Patient went to urgent care and received valacyclovir (manufacturer unknown) 1 mg 3 tabs for 7 days (reported as first dose on 25Mar2021 and last dose tonight) as a result of shingles. The outcome of all events reported was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Vaccination site pain
Clinical narrative: soreness at the injection site; broke out in shingles; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at 1st dose, single for COVID-19 immunisation. Medical history included COVID in 2019 and in 2020 (the 1st time was in 2019, and the 2nd time was in 2020). The patient's concomitant medications were not reported. The patient previously had 2 shingle shots last year in 2020. On the 2nd time she had the virus, she quarantined for 2 weeks with her daughter. She said she received the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine today (01Apr2021, at the time of report). However, after her 1st dose, she said she experienced soreness at the injection site, and felt as if a truck ran over her. She also said she broke out in shingles. The patient experienced soreness at the injection site and broke out in shingles on an unspecified date. The patient said that she already had 2 shingle shots last year so she was confused as to why the vaccine would cause her to get it again. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with shingles; This is a spontaneous report from a contactable consumer. This consumer reported the same event for two patients. This is second of two reports.  A contactable consumer reported that a patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at an unknown dose number, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was diagnosed with shingles on an unspecified date. The outcome of the event was unknown.   Follow-up attempts not completed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021361731 same reporter/drug/event, different patient
Sex: U
Vaccine: COVID19
Symptoms: Asthma, Cerebral disorder, Confusional state, Herpes zoster
Clinical narrative: kind of confused with this shingles my brain is not acting right; kind of confused with this shingles my brain is not acting right; Shingles; Asthma; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on an unspecified date on Mar2021 as first dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient initially reported rash, swollen lymph nodes, and asthma on 25Mar2021 . Patient reported that it was getting painful and he/she went to the doctor. Patient was then diagnosed with shingles on 26Mar2021 as confirmed by his/her doctor (reported as developed 36 hours after the shot). Patient also reported on an unspecified date that he/she was kind of confused with this shingles, his/her brain was not acting right. Patient went to the doctor as a result of shingles. The outcome of all events reported was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Investigation, Physical examination
Clinical narrative: Broke out in shingles; This is a spontaneous report from a contactable consumer reported for herself . A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported (reported as CN6206, for confirmation), via an unspecified route of administration, at the age of 66 years, on 13Mar2021 as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history was reported as none. The patient stated, "Not sure if this is, if you are the right person to help me, I broke out in shingles. I had my first vaccine two and a half weeks ago and let's see about 5 days ago I broke out with shingles (Mar2021). Now my concern is I am schedule to get another vaccine this Saturday and I talked to a pharmacist and she had a concern about whether or not I should get the second vaccine now or if I should push it off. Apparently she told me there is now a 42 days span of time in which I can get it instead of three weeks." The patient underwent lab tests and procedures which included investigation: unknown results on 26Mar2021 and physical examination: unknown results on 26Mar2021. Therapeutic measures were taken as a result of broke out in shingles (herpes zoster). The patient stated "I am taking, yes doctor gave me medication to retract." The outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort, Facial pain, Herpes zoster, Hypersensitivity, Scab
Clinical narrative: scabbing; shingles; marking that showed up on the face/sore dried up on his face; allergic reaction; swelling on neck and cheek; swelling on neck and cheek; tooth ache; stuffiness in ear; pain right side of the face; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6207), via an unspecified route of administration, administered in arm on 19Mar2021 10:00 (at the age of 63 years old) as 1st dose, single "to get myself vaccinated". Medical history was reported as none. There were no concomitant medications. The patient called about the COVID 19 vaccine, stated that he had side effects that he felt he needed to report and questioned if he needed to know anything before getting the second dose. He stated that he received the first dose on 19Mar2021 and on Sunday (21Mar2021) he began to have symptoms. He stated on Sunday 21Mar2021, he had swelling on his neck and cheek and stuffiness in his ear which he thought might had been a tooth ache or an allergic reaction. He stated that a few days after those symptoms developed he had pain on the right side of his face on 21Mar2021 and markings that showed up on his face on 22Mar2021. Further stated that he went to the urgent care as there was no need to go to the emergency room on 25Mar2021 and was diagnosed with shingles. He began treatment that day for shingles on his right side of his face and it was a seven day course of medication and his last treatment will be finished at the end of that day of the report. He reported that the markings were better and he did not have nerve pain and the sore dried up on his face which was consistent. He went to the doctor on 29Mar2021 just to be on the safe side and the symptoms seemed to be better. He received the next vaccine on 09Apr2021. Further stated he thought it would be good to report his symptoms and see if there was anything Pfizer could tell him. Further stated that the scabbing on unspecified date was getting better. Treatment was valacyclovir. Therapeutic measures were taken as a result of all of the events. The outcome of the event tooth ache and allergic reaction were unknown; pain right side of the face was resolved on 29Mar2021; stuffiness in ear, swelling on neck and cheek were recovered on 31Mar2021; shingles and marking that showed up on the face were recovering.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Skin lesion, Swelling, Swelling face, Toothache
Clinical narrative: scabbing; shingles; marking that showed up on the face/sore dried up on his face; allergic reaction; swelling on neck and cheek; swelling on neck and cheek; tooth ache; stuffiness in ear; pain right side of the face; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6207), via an unspecified route of administration, administered in arm on 19Mar2021 10:00 (at the age of 63 years old) as 1st dose, single "to get myself vaccinated". Medical history was reported as none. There were no concomitant medications. The patient called about the COVID 19 vaccine, stated that he had side effects that he felt he needed to report and questioned if he needed to know anything before getting the second dose. He stated that he received the first dose on 19Mar2021 and on Sunday (21Mar2021) he began to have symptoms. He stated on Sunday 21Mar2021, he had swelling on his neck and cheek and stuffiness in his ear which he thought might had been a tooth ache or an allergic reaction. He stated that a few days after those symptoms developed he had pain on the right side of his face on 21Mar2021 and markings that showed up on his face on 22Mar2021. Further stated that he went to the urgent care as there was no need to go to the emergency room on 25Mar2021 and was diagnosed with shingles. He began treatment that day for shingles on his right side of his face and it was a seven day course of medication and his last treatment will be finished at the end of that day of the report. He reported that the markings were better and he did not have nerve pain and the sore dried up on his face which was consistent. He went to the doctor on 29Mar2021 just to be on the safe side and the symptoms seemed to be better. He received the next vaccine on 09Apr2021. Further stated he thought it would be good to report his symptoms and see if there was anything Pfizer could tell him. Further stated that the scabbing on unspecified date was getting better. Treatment was valacyclovir. Therapeutic measures were taken as a result of all of the events. The outcome of the event tooth ache and allergic reaction were unknown; pain right side of the face was resolved on 29Mar2021; stuffiness in ear, swelling on neck and cheek were recovered on 31Mar2021; shingles and marking that showed up on the face were recovering.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer. An 87-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 08Mar2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced shingles on an unspecified date. The patient's second dose is scheduled on 29Mar2021 however, they rescheduled the second dose on 05Apr2021 because she experienced shingles after the first dose. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Feeling unwell; This is a spontaneous report from a Pfizer-Sponsored program. from a contactable consumer (patient). A 79-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation and estrogens conjugated (PREMARIN) for hot flush. Medical history and concomitant medications were not reported. The patient experienced feeling unwell (non-serious) on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Ear infection
Clinical narrative: ear infection; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient reported she had many comorbidities and was due for her second dose of BNT162B2 in a few days. She reported she had an ear infection and her doctor was out of town, so she was taking hydrastis canadensis (GOLDENSEAL) to treat. She inquired if there would be any interactions between hydrastis canadensis and BNT162B2. The clinical outcome of ear infection was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.